Suppr超能文献

威斯康星大学卡本癌症中心口服化疗给药的多学科优化

Multidisciplinary Optimization of Oral Chemotherapy Delivery at the University of Wisconsin Carbone Cancer Center.

作者信息

Mulkerin Daniel L, Bergsbaken Jason J, Fischer Jessica A, Mulkerin Mary J, Bohler Aaron M, Mably Mary S

机构信息

University of Wisconsin Carbone Cancer Center; UW Health, Madison, WI; and Riverside Health System, Newport News, VA.

出版信息

J Oncol Pract. 2016 Oct;12(10):e912-e923. doi: 10.1200/JOP.2016.013748.

Abstract

PURPOSE

Use of oral chemotherapy is expanding and offers advantages while posing unique safety challenges. ASCO and the Oncology Nursing Society jointly published safety standards for administering chemotherapy that offer a framework for improving oral chemotherapy practice at the University of Wisconsin Carbone Cancer Center.

METHODS

With the goal of improving safety, quality, and uniformity within our oral chemotherapy practice, we conducted a gap analysis comparing our practice against ASCO/Oncology Nursing Society guidelines. Areas for improvement were addressed by multidisciplinary workgroups that focused on education, workflows, and information technology. Recommendations and process changes included defining chemotherapy, standardizing patient and caregiver education, mandating the use of comprehensive electronic order sets, and standardizing documentation for dose modification. Revised processes allow pharmacists to review all orders for oral chemotherapy, and they support monitoring adherence and toxicity by using a library of scripted materials.

RESULTS

Between August 2015 and January 2016, revised processes were implemented across the University of Wisconsin Carbone Cancer Center clinics. The following are key performance indicators: 92.5% of oral chemotherapy orders (n = 1,216) were initiated within comprehensive electronic order sets (N = 1,315), 89.2% compliance with informed consent was achieved, 14.7% of orders (n = 193) required an average of 4.4 minutes review time by the pharmacist, and 100% compliance with first-cycle monitoring of adherence and toxicity was achieved.

CONCLUSION

We closed significant gaps between institutional practice and published standards for our oral chemotherapy practice and experienced steady improvement and sustainable performance in key metrics. We created an electronic definition of oral chemotherapies that allowed us to leverage our electronic health records. We believe our tools are broadly applicable.

摘要

目的

口服化疗的应用正在扩大,它具有诸多优势,但也带来了独特的安全挑战。美国临床肿瘤学会(ASCO)和肿瘤护理学会联合发布了化疗给药安全标准,为威斯康星大学卡本癌症中心改善口服化疗实践提供了一个框架。

方法

为了提高口服化疗实践中的安全性、质量和一致性,我们进行了差距分析,将我们的实践与ASCO/肿瘤护理学会的指南进行比较。多学科工作组针对改进领域展开工作,重点关注教育、工作流程和信息技术。建议和流程变更包括定义化疗、规范患者及护理人员教育、强制使用综合电子医嘱集以及规范剂量调整的文档记录。修订后的流程使药剂师能够审查所有口服化疗医嘱,并通过使用一系列书面材料库来支持对依从性和毒性的监测。

结果

2015年8月至2016年1月期间,威斯康星大学卡本癌症中心的各个诊所实施了修订后的流程。以下是关键绩效指标:92.5%的口服化疗医嘱(n = 1216)在综合电子医嘱集中启动(N = 1315),知情同意的依从率达到89.2%,14.7%的医嘱(n = 193)平均需要药剂师4.4分钟的审查时间,并且在依从性和毒性的首次周期监测方面实现了10​​0%的依从率。

结论

我们缩小了机构实践与已发布的口服化疗实践标准之间的显著差距,并在关键指标上实现了稳步改进和可持续的表现。我们创建了口服化疗药物的电子定义,使我们能够利用电子健康记录。我们相信我们的工具具有广泛的适用性。

相似文献

2
The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
J Oncol Pharm Pract. 2017 Dec;23(8):582-590. doi: 10.1177/1078155216672314. Epub 2016 Oct 12.
4
Survey of oral chemotherapy safety and adherence practices of hospitals in Spain.
Int J Clin Pharm. 2013 Dec;35(6):1236-44. doi: 10.1007/s11096-013-9858-9. Epub 2013 Oct 16.
5
Improving adherence with oral antiemetic agents in patients with breast cancer receiving chemotherapy.
J Oncol Pract. 2015 May;11(3):216-8. doi: 10.1200/JOP.2015.004234. Epub 2015 Apr 14.
6
Conversion from paper to electronic acute care chemotherapy orders.
Am J Health Syst Pharm. 2020 Sep 4;77(18):1516-1521. doi: 10.1093/ajhp/zxaa201.
7
Oral chemotherapy safety practices at US cancer centres: questionnaire survey.
BMJ. 2007 Feb 24;334(7590):407. doi: 10.1136/bmj.39069.489757.55. Epub 2007 Jan 12.
8
Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management.
J Oncol Pharm Pract. 2017 Dec;23(8):563-574. doi: 10.1177/1078155216665247. Epub 2016 Aug 29.

本文引用的文献

1
Improving the Safety of Oral Chemotherapy at an Academic Medical Center.
J Oncol Pract. 2016 Jan;12(1):e71-6. doi: 10.1200/JOP.2015.007260. Epub 2016 Jan 5.
2
ReCAP: Comparison of Independent Error Checks for Oral Versus Intravenous Chemotherapy.
J Oncol Pract. 2016 Feb;12(2):168-9; e180-7. doi: 10.1200/JOP.2015.005892. Epub 2015 Sep 29.
4
Oral chemotherapy practices at Ontario cancer centres.
J Oncol Pharm Pract. 2015 Aug;21(4):249-57. doi: 10.1177/1078155214528830. Epub 2014 Apr 8.
6
Acceptance of oral chemotherapy in breast cancer patients - a survey study.
BMC Cancer. 2011 Apr 12;11:129. doi: 10.1186/1471-2407-11-129.
7
NCCN Task Force Report: Oral chemotherapy.
J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1-14.
8
Overview of the changing paradigm in cancer treatment: oral chemotherapy.
Am J Health Syst Pharm. 2007 May 1;64(9 Suppl 5):S4-7. doi: 10.2146/ajhp070035.
9
Oral chemotherapy safety practices at US cancer centres: questionnaire survey.
BMJ. 2007 Feb 24;334(7590):407. doi: 10.1136/bmj.39069.489757.55. Epub 2007 Jan 12.
10
Patient preferences for oral versus intravenous palliative chemotherapy.
J Clin Oncol. 1997 Jan;15(1):110-5. doi: 10.1200/JCO.1997.15.1.110.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验